Cannabus Company (Pty) Ltd and FasterCapital today announced a strategic partnership through FasterCapital’s Equitypilot program to accelerate commercialisation of cannabis infused skincare & haircare products, scale a GMP-certified cannabis agro-processing facility in South Africa and target global markets. The collaboration combines Cannabus’s product innovation and CSIR manufacturing track record with Equitypilot’s capital, mentorship and go-to-market resources.
Market opportunity & problem statement
South Africa’s cosmetics market (estimated at $193.7M in 2022, CAGR 5.6%) shows rising demand for natural, multifunctional skincare. Current pain points include ineffective topical remedies for growing natural hair, skin inflammation and muscle pain, limited locally manufactured cannabis-infused products, and fragmented supply chains. Cannabus addresses this white space with plant-based, clinically informed formulations and a roadmap to domestic extraction capacity, offering a differentiated South African brand in an under‑served segment.
Startup solution & differentiation
Cannabus’s flagship Cannabus Hempseed Body Butter (250ml) and Cannabus CBD Hair Butter (250ml) blends hempseed, rosehip, lavender and chamomile oils in a shea butter base to target skin and hair problems such as muscle pain, skin inflammation, stunted hair growth and scalp conditioning while delivering premium benefits. Developed with CSIR, the products are market-ready, priced competitively at $12, and benefits from certifications and supplier COAs. Proprietary formulation IP, planned GMP production, and an omnichannel retail strategy (pharmacies, e‑commerce, spas) create defensible positioning against mass-market incumbents.
FasterCapital partnership value
Through Equitypilot, Cannabus will access FasterCapital’s global investor network, technical mentorship, fundraising support and business acceleration services, including go-to-market playbooks and connections for GMP certifiers and extraction equipment suppliers. FasterCapital applies rigorous selection and acceleration criteria; Cannabus was chosen for its traction, science-backed formulation and scalable manufacturing plan. Expected outcomes include a completed seed round, facility construction kick-off and first-party extraction by 2026.
“FasterCapital invests where technical innovation meets clear market demand. Cannabus combines rigorous R&D with an executable manufacturing roadmap a precise fit for Equitypilot,” said Hesham Zreik, reflecting FasterCapital’s investment thesis.
Prestige Mbito, CEO of Cannabus Company, said: “This partnership turbocharges our plan to build a GMP cannabis agro‑processing hub and bring clinically credible, locally made cannabis-infused products to consumers across South Africa and beyond. FasterCapital’s capital and mentorship will shorten our path to scale.”
